000 01045 a2200337 4500
005 20250513140007.0
264 0 _c19980409
008 199804s 0 0 eng d
022 _a0022-5347
040 _aNLM
_beng
_cNLM
100 1 _aPannek, J
245 0 0 _aThe use of percent free prostate specific antigen for staging clinically localized prostate cancer.
_h[electronic resource]
260 _bThe Journal of urology
_cApr 1998
300 _a1238-42 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aPredictive Value of Tests
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aSensitivity and Specificity
700 1 _aRittenhouse, H G
700 1 _aChan, D W
700 1 _aEpstein, J I
700 1 _aWalsh, P C
700 1 _aPartin, A W
773 0 _tThe Journal of urology
_gvol. 159
_gno. 4
_gp. 1238-42
999 _c9475666
_d9475666